drugset / Trial / NCT02071914

A Study to Evaluate the Efficacy and Safety of CT-P27 in an Influenza Challenge Model

NCT02071914 ↗

Phase 2 Completed 81 enrolled Celltrion
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to evaluate the efficacy of CT-P27 measured by quantitative PCR viral load from nasopharyngeal mucosa, compared to placebo.

Timeline

Start
2014-02-15
Primary completion
2014-05-19
Completion
2014-06-19

Drugs

EvaluationDrugModalityDoseRoute
Subject CT-P27 Unknown 10 mg/kg Intravenous
Subject CT-P27 Unknown 20 mg/kg Intravenous

Indications